1721 - 1730 of 6509 Results
Title
Year
-
OPENTitle: Longitudinal evaluation of olfactory function in individuals with Gaucher disease and GBA1 mutation carriers with and without Parkinson's diseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page: 1039214End Page: 1039214Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.1039214Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.1039214/pdfCitation Count: 8
-
OPENTitle: Targeting the inflammasome in Parkinson’s diseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page: 957705End Page: 957705Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.957705Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.957705/pdfCitation Count: 23
-
OPENTitle: Elevated Plasma Phosphorylated Tau 181 in Amyotrophic Lateral SclerosisJournal Name: Annals of NeurologyPublisher: WileyVol: 92Issue #: 5Start Page: 807End Page: 818Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.26462Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9588516Citation Count: 50
-
OPENTitle: The impact of harmonization on radiomic features in Parkinson’s disease and healthy controls: A multicenter studyJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page: 1012287End Page: 1012287Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2022.1012287Best OA location URL: https://doi.org/10.3389/fnins.2022.1012287Citation Count: 26
-
OPENTitle: Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesiaJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page: 846126End Page: 846126Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.846126Best OA location URL: https://doi.org/10.3389/fneur.2022.846126Citation Count: 7
-
OPENTitle: Intraindividual variability in neuropsychological performance predicts longitudinal cortical volume loss in early Parkinson’s disease.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 36Issue #: 6Start Page: 513End Page: 519Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1037/neu0000809Best OA location URL: https://doi.org/10.1037/neu0000809Citation Count: 7
- Detecting motor symptom fluctuations in Parkinson’s disease with generative adversarial networks2022OPENTitle: Detecting motor symptom fluctuations in Parkinson’s disease with generative adversarial networksJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page: 138End Page: 138Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41746-022-00674-xBest OA location URL: https://www.nature.com/articles/s41746-022-00674-x.pdfCitation Count: 35
-
OPENTitle: Evaluation of Disability Progression in Multiple Sclerosis via Magnetic-Resonance-Based Deep Learning TechniquesJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 23Issue #: 18Start Page: 10651End Page: 10651Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms231810651Best OA location URL: https://www.mdpi.com/1422-0067/23/18/10651/pdf?version=1663318573Citation Count: 14
-
OPENTitle: Brain-restricted mTOR inhibition with binary pharmacologyJournal Name: NaturePublisher: Springer Science and Business Media LLCVol: 609Issue #: 7928Start Page: 822End Page: 828Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41586-022-05213-yBest OA location URL: https://www.nature.com/articles/s41586-022-05213-y.pdfCitation Count: 78
-
OPENTitle: Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degenerationJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page: 5308End Page: 5308Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-022-32944-3Best OA location URL: https://www.nature.com/articles/s41467-022-32944-3.pdfCitation Count: 57